• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

牛磺熊去氧胆酸在分离的大鼠肝细胞中激活蛋白激酶C。

Tauroursodeoxycholic acid activates protein kinase C in isolated rat hepatocytes.

作者信息

Beuers U, Throckmorton D C, Anderson M S, Isales C M, Thasler W, Kullak-Ublick G A, Sauter G, Koebe H G, Paumgartner G, Boyer J L

机构信息

Department of Internal Medicne, Yale University School of Medicine, New Haven Connecticut, USA.

出版信息

Gastroenterology. 1996 May;110(5):1553-63. doi: 10.1053/gast.1996.v110.pm8613063.

DOI:10.1053/gast.1996.v110.pm8613063
PMID:8613063
Abstract

BACKGROUND & AIMS: Ursodeoxycholic acid (UDCA) improves liver function in patients with chronic cholestatic liver diseases by an unknown mechanism. UDCA is conjugated to taurine in vivo, and tauroursodeoxycholic acid (TUDCA) is a potent hepatocellular Ca2+ agonist and stimulates biliary exocytosis and hepatocellular Ca2+ influx, both of which are defective in experimental cholestasis. Protein kinase C (PKC) mediates stimulation of exocytosis in the liver. The aim of this study was to determine the effects of TUDCA on PKC in isolated hepatocytes.

METHODS

The effect of TUDCA on the distribution of PKC isoenzymes within the hepatocyte was studied using immunoblotting and immunofluorescence techniques. In addition, the effect of TUDCA on the accummulation of sn-1,2-diacylglycerol (DAG), the intracellular activator of PKC, and hepatocellular PKC activity was studied using radioenzymatic techniques.

RESULTS

Immunoblotting studies showed the presence of four isoenzymes (alpha, delta, epsilon, and zeta). The phorbol ester phorbol 12-myristate 13-acetate (1 mumol/L) induced translocation of alpha-PKC, delta-PKC, and epsilon-PKC from cytosol to a particulate membrane fraction, a key step for activation of PKC. TUDCA, but not taurocholic acid, selectively induced translocation of the alpha-PKC isoenzyme from cytosol to the membranes. In addition, TUDCA induced a significant increase in hepatocellular DAG mass and stimulated membrane-associated PKC activity.

CONCLUSIONS

TUDCA might stimulate Ca(2+)-dependent hepatocellular exocytosis into bile in part by activation of alpha-PKC.

摘要

背景与目的

熊去氧胆酸(UDCA)可改善慢性胆汁淤积性肝病患者的肝功能,但其机制尚不明确。UDCA在体内与牛磺酸结合,牛磺熊去氧胆酸(TUDCA)是一种有效的肝细胞Ca2+激动剂,可刺激胆汁分泌和肝细胞Ca2+内流,而这两者在实验性胆汁淤积中均存在缺陷。蛋白激酶C(PKC)介导肝脏中的分泌刺激作用。本研究旨在确定TUDCA对分离的肝细胞中PKC的影响。

方法

采用免疫印迹和免疫荧光技术研究TUDCA对肝细胞内PKC同工酶分布的影响。此外,采用放射酶法研究TUDCA对PKC的细胞内激活剂sn-1,2-二酰甘油(DAG)积累及肝细胞PKC活性的影响。

结果

免疫印迹研究显示存在四种同工酶(α、δ、ε和ζ)。佛波酯佛波醇12-肉豆蔻酸酯13-乙酸酯(1 μmol/L)诱导α-PKC、δ-PKC和ε-PKC从细胞质向颗粒膜部分转位,这是PKC激活的关键步骤。TUDCA而非牛磺胆酸选择性地诱导α-PKC同工酶从细胞质向膜转位。此外,TUDCA导致肝细胞DAG含量显著增加,并刺激膜相关PKC活性。

结论

TUDCA可能部分通过激活α-PKC刺激Ca(2+)依赖性肝细胞向胆汁的分泌。

相似文献

1
Tauroursodeoxycholic acid activates protein kinase C in isolated rat hepatocytes.牛磺熊去氧胆酸在分离的大鼠肝细胞中激活蛋白激酶C。
Gastroenterology. 1996 May;110(5):1553-63. doi: 10.1053/gast.1996.v110.pm8613063.
2
Tauroursodeoxycholic acid inserts the apical conjugate export pump, Mrp2, into canalicular membranes and stimulates organic anion secretion by protein kinase C-dependent mechanisms in cholestatic rat liver.牛磺熊去氧胆酸将顶端结合物输出泵Mrp2插入胆小管膜,并通过蛋白激酶C依赖性机制刺激胆汁淤积大鼠肝脏中的有机阴离子分泌。
Hepatology. 2001 May;33(5):1206-16. doi: 10.1053/jhep.2001.24034.
3
Tauroursodeoxycholic acid stimulates hepatocellular exocytosis and mobilizes extracellular Ca++ mechanisms defective in cholestasis.牛磺熊去氧胆酸刺激肝细胞胞吐作用,并调动胆汁淤积中存在缺陷的细胞外Ca++机制。
J Clin Invest. 1993 Dec;92(6):2984-93. doi: 10.1172/JCI116921.
4
Tauroursodeoxycholic acid exerts anticholestatic effects by a cooperative cPKC alpha-/PKA-dependent mechanism in rat liver.牛磺熊去氧胆酸通过大鼠肝脏中一种协同的依赖于蛋白激酶Cα/蛋白激酶A的机制发挥抗胆汁淤积作用。
Gut. 2008 Oct;57(10):1448-54. doi: 10.1136/gut.2007.140871. Epub 2008 Jun 26.
5
Tauroursodeoxycholic acid mobilizes alpha-PKC after uptake in human HepG2 hepatoma cells.牛磺熊去氧胆酸在被人HepG2肝癌细胞摄取后可动员α-蛋白激酶C。
Eur J Clin Invest. 2002 Jun;32(6):437-42. doi: 10.1046/j.1365-2362.2002.01002.x.
6
Modulation of protein kinase C by taurolithocholic acid in isolated rat hepatocytes.牛磺石胆酸对离体大鼠肝细胞中蛋白激酶C的调节作用。
Hepatology. 1999 Feb;29(2):477-82. doi: 10.1002/hep.510290227.
7
Hepatocellular protein kinase C activation by bile acids: implications for regulation of cholesterol 7 alpha-hydroxylase.胆汁酸对肝细胞蛋白激酶C的激活作用:对胆固醇7α-羟化酶调节的影响
Am J Physiol. 1996 Aug;271(2 Pt 1):G293-303. doi: 10.1152/ajpgi.1996.271.2.G293.
8
Activation of protein kinase C alpha and delta by bile acids: correlation with bile acid structure and diacylglycerol formation.胆汁酸对蛋白激酶Cα和δ的激活作用:与胆汁酸结构及二酰基甘油形成的相关性
J Lipid Res. 1997 Dec;38(12):2446-54.
9
Ursodeoxycholate and tauroursodeoxycholate inhibit cholangiocyte growth and secretion of BDL rats through activation of PKC alpha.熊去氧胆酸和牛磺熊去氧胆酸通过激活蛋白激酶Cα抑制胆管结扎大鼠胆管细胞的生长和分泌。
Hepatology. 2002 May;35(5):1041-52. doi: 10.1053/jhep.2002.32712.
10
Effect of phorbol ester and platelet-derived growth factor on protein kinase C in rat hepatic stellate cells.佛波酯和血小板衍生生长因子对大鼠肝星状细胞中蛋白激酶C的影响。
Liver Int. 2007 Oct;27(8):1066-75. doi: 10.1111/j.1478-3231.2007.01573.x.

引用本文的文献

1
Bile acid therapy for primary biliary cholangitis: Pathogenetic validation.原发性胆汁性胆管炎的胆汁酸疗法:发病机制验证。
World J Exp Med. 2025 Mar 20;15(1):101771. doi: 10.5493/wjem.v15.i1.101771.
2
Post-Translational Modifications of FXR; Implications for Cholestasis and Obesity-Related Disorders.FXR 的翻译后修饰;对胆汁淤积和肥胖相关疾病的影响。
Front Endocrinol (Lausanne). 2021 Sep 27;12:729828. doi: 10.3389/fendo.2021.729828. eCollection 2021.
3
Tauroursodeoxycholate-Bile Acid with Chaperoning Activity: Molecular and Cellular Effects and Therapeutic Perspectives.
牛磺熊去氧胆酸-具有伴侣活性的胆汁酸:分子和细胞作用及治疗前景。
Cells. 2019 Nov 20;8(12):1471. doi: 10.3390/cells8121471.
4
Mechanism of inhibition of taurolithocholate-induced retrieval of plasma membrane MRP2 by cyclic AMP and tauroursodeoxycholate.环磷酸腺苷和牛磺熊去氧胆酸抑制牛磺石胆酸诱导的质膜多药耐药相关蛋白2回收的机制。
Physiol Rep. 2017 Dec;5(23). doi: 10.14814/phy2.13529.
5
Administration of Tauroursodeoxycholic Acid Attenuates Early Brain Injury via Akt Pathway Activation.牛磺熊去氧胆酸的给药通过激活Akt途径减轻早期脑损伤。
Front Cell Neurosci. 2017 Jul 6;11:193. doi: 10.3389/fncel.2017.00193. eCollection 2017.
6
PKCβ: Expanding role in hepatic adaptation of cholesterol homeostasis to dietary fat/cholesterol.蛋白激酶Cβ:在肝脏对饮食中脂肪/胆固醇的胆固醇稳态适应过程中的作用不断扩展。
Am J Physiol Gastrointest Liver Physiol. 2017 Mar 1;312(3):G266-G273. doi: 10.1152/ajpgi.00373.2016. Epub 2017 Jan 19.
7
Application of Tauroursodeoxycholic Acid for Treatment of Neurological and Non-neurological Diseases: Is There a Potential for Treating Traumatic Brain Injury?牛磺熊去氧胆酸在神经和非神经疾病治疗中的应用:治疗创伤性脑损伤是否具有潜力?
Neurocrit Care. 2016 Aug;25(1):153-66. doi: 10.1007/s12028-015-0225-7.
8
Canalicular membrane MRP2/ABCC2 internalization is determined by Ezrin Thr567 phosphorylation in human obstructive cholestasis.在人类梗阻性胆汁淤积中,胆小管膜MRP2/ABCC2内化由埃兹蛋白Thr567磷酸化决定。
J Hepatol. 2015 Dec;63(6):1440-8. doi: 10.1016/j.jhep.2015.07.016. Epub 2015 Jul 23.
9
Novel therapeutic targets in primary biliary cirrhosis.原发性胆汁性肝硬化的新型治疗靶点。
Nat Rev Gastroenterol Hepatol. 2015 Mar;12(3):147-58. doi: 10.1038/nrgastro.2015.12. Epub 2015 Feb 3.
10
INTRACELLULAR SIGNALING BY BILE ACIDS.胆汁酸的细胞内信号传导
J Biosci (Rajshari). 2012;20:1-23. doi: 10.3329/jbs.v20i0.17647.